加拿大因严格条例造成的药品短缺威胁到动物护理和农业产出。 Canada's vet drug shortage, caused by strict regulations, threatens animal care and farm output.

加拿大兽医报告说,动物药物严重短缺,由于加拿大卫生部2017年的监管变化,需要昂贵的外国制造业检查,近40%的以前可获得的药物现在无法使用。 Canadian veterinarians report a severe shortage of animal medications, with nearly 40% of previously available drugs now inaccessible due to Health Canada’s 2017 regulatory changes requiring costly foreign manufacturing inspections. 这一规则阻遏了国际药物制造者,特别是考虑到加拿大市场小,导致美国和欧洲缺乏安全有效的治疗方法。 The rule deters international drug makers, especially given Canada’s small market, leading to unavailability of safe, effective treatments used in the U.S. and Europe. 这影响到牲畜和宠物照料,破坏农场生产力和动物福利,并可能提高消费者成本。 This affects livestock and pet care, disrupting farm productivity and animal welfare, and may raise consumer costs. 加拿大卫生部表示, 通过更快的审查和有条件的批准, 改善获取途径, 但兽医们敦促渥太华与美国和欧洲监管者协调审批流程, 简化获取途径。 Health Canada says it’s improving access through faster reviews and conditional approvals, but veterinarians urge Ottawa to harmonize approval processes with U.S. and European regulators to streamline access.